P
Paula S. Stuart
Researcher at Wake Forest University
Publications - 10
Citations - 309
Paula S. Stuart is an academic researcher from Wake Forest University. The author has contributed to research in topics: Gastroparesis & Nausea. The author has an hindex of 5, co-authored 10 publications receiving 166 citations.
Papers
More filters
Journal ArticleDOI
Aprepitant Has Mixed Effects on Nausea and Reduces Other Symptoms in Patients With Gastroparesis and Related Disorders
Pankaj J. Pasricha,Katherine P. Yates,Irene Sarosiek,Richard W. McCallum,Thomas L. Abell,Kenneth L. Koch,Linda Anh B. Nguyen,William J. Snape,William L. Hasler,John O. Clarke,Sameer Dhalla,Ellen M. Stein,Linda A. Lee,Laura Miriel,Mark L. Van Natta,Madhusudan Grover,Gianrico Farrugia,James Tonascia,Frank A. Hamilton,Henry P. Parkman,Nata DeVole,Karen Earle,Kjersti Kirkeby,Candice Lee,Mimi Lin,Katie Ponting,Gloria Yee,P. J. Pasricha,Ellen Stein,Yale Kim,Gotzone Garay,Chiara Orlando,Alan Mauer,Perry Orthey,Amiya Palit,Sean Connery,Yvette Gomez,Roberta Romero,Natalia Vega,Ben Alvarado,Lisa Hatter,Ronna Howard,Lindsay Nowotny,William H. Herman,Andrew T. Kraftson,Amy E. Rothberg,Sophanara Wootten,Lynn Baxter,Anya Brown,Paula S. Stuart,Samantha Culler,Cheryl E. Bernard,Frank Hamilton,Jose Serrano,Stephen P. James,Rebecca Torrance,Sherry Hall,Patricia Belt,John Dodge,Michele Donithan,Erin Hallinan,Milana Isaacson,Patrick May,Laura Miriel,Alice L. Sternberg,Mark L. Van Natta,Annette Wagoner,Laura Wilson +67 more
TL;DR: The findings of this randomized trial of the ability of the neurokinin-1 receptor antagonist aprepitant to reduce symptoms in patients with chronic nausea and vomiting caused by gastropareis or gastroparesis-like syndrome support the need to identify appropriate patient outcomes for trials of therapies for gastroparedis.
Journal ArticleDOI
Functional Dyspepsia and Gastroparesis in Tertiary Care are Interchangeable Syndromes With Common Clinical and Pathologic Features.
P. J. Pasricha,Madhusudan Grover,Katherine P. Yates,Thomas L. Abell,Cheryl E. Bernard,Kenneth L. Koch,Richard W. McCallum,Irene Sarosiek,Braden Kuo,Robert S. Bulat,Jiande Chen,Robert J. Shulman,Linda Lee,James Tonascia,Laura Miriel,Frank A. Hamilton,Gianrico Farrugia,Henry P. Parkman,Pankaj J. Pasricha,Robert Burns,Guillermo Barahona Hernandez,Megan McKnight,April Mendez,Kyle Staller,Andrea H. Thurler,Christopher Velez,Casey J. Silvernale,Zubair Malik,Alan H. Maurer,Amiya Palit,Natalia Vega,Denise Vasquez,Sean Connery,Karina Espino,Marvin Friedman,Thomas L. Abell,Abigail Stocker,Bridget Cannon,Lindsay McElmurray,Kelly Cooper,Catherine McBride,Kenneth L. Koch,Lynn Baxter,Anya Brown,Paula S. Stuart,Amirah Abdullah,William J. Snape,Nata DeVole,Karen Earle,Kjersti Kirkeby,Candice Lee,Mimi Lin,Doug Troyer,Anna von Bakonyi,Robert Shulman,Bruno P. Chumpitazi,Liz Febo-Rodriguez,John Hollier,Cynthia Bouette,Heather Charron,Samuel Nurko,Stephanie Wall,Madeline Kane,Kent C. Williams,Lina Yossef-Salameh,Frederick W. Woodley,Cheryl Bernard,Jose Serrano,Sherry Hall,Stephen P. James,Rebecca Torrance,Margaret Adamo,Patricia Belt,John Dodge,Michele Donithan,Milana Isaacson,Jill Meinert,Laura Miriel,Emily P. Sharkey,Jacqueline Smith,Mike Smith,Alice L. Sternberg,Mark L. Van Natta,Annette Wagoner,Laura Wilson,Goro Yamada,Katherine Yates +86 more
TL;DR: In this paper, the pathophysiology of functional dyspepsia (FD), a highly prevalent gastrointestinal syndrome, and its relationship with the better-understood syndrome of gastroparesis were clarified.
Journal ArticleDOI
Opioid Use and Potency Are Associated With Clinical Features, Quality of Life, and Use of Resources in Patients With Gastroparesis.
William L. Hasler,Laura A. Wilson,Linda A. Nguyen,William J. Snape,Thomas L. Abell,Kenneth L. Koch,Richard W. McCallum,P. J. Pasricha,Irene Sarosiek,Gianrico Farrugia,Madhusudan Grover,Linda A. Lee,Laura Miriel,James Tonascia,Frank A. Hamilton,Henry P. Parkman,Pankaj J. Pasricha,John O. Clarke,Yale Kim,Linda Nguyen,Nighat Ullah,William J. Snape,Nata DeVole,Mary Greene,Candice Lee,Courtney Ponsetto,Katerina Shetler,Steven Kantor,Vanessa Lytes,Amiya Palit,Kellie Simmons,Reza Hejazi,Kathy Roeser,Denise Vasquez,Natalia Vega,Thomas L. Abell,Karen Beatty,Lisa Hatter,Ronna Howard,Lindsay Nowotny,Shou Tang,Om S. Amin,Olivia Henry,Archana Kedar,Valerie McNair,Susanne Pruett,Margaret Smith,Danielle Spree,William L. Hasler,Michelle Castle,Radoslav Coleski,Sophanara Wootten,Kenneth L. Koch,Lynn Baxter,Anya Brown,Samantha Culler,Judy Hooker,Paula S. Stuart,Cheryl E. Bernard,Jorge Calles-Escandon,Jose Serrano,Frank Hamilton,Steven James,Rebecca Torrance,Rebekah Van Raaphorst,Patricia Belt,Erin Corless Hallinan,Ryan Colvin,Michele Donithan,Mika Green,Milana Isaacson,Wana Kim,Linda Lee,Patrick May,Alice L. Sternberg,Mark L. Van Natta,Ivana A. Vaughn,Laura Wilson,Katherine P. Yates +78 more
TL;DR: Opioid use is prevalent among patients with diabetic or idiopathic gastroparesis, and is associated with worse symptoms, delays in gastric emptying, and lower quality of life, as well as greater use of resources.
Journal ArticleDOI
Effect of endoscopic pyloric therapies for patients with nausea and vomiting and functional obstructive gastroparesis
TL;DR: Pyloric therapies appear to be effective treatments in symptomatic patients with GP and 3cpm GMA and controlled trials are warranted.
Journal ArticleDOI
Obstructive Gastroparesis: Patient Selection and Effect of Laparoscopic Pyloroplasty.
TL;DR: Pyloroplasty in patients with obstructive gastroparesis improved gastric emptying and decreased 3 cycle per minute gastric myoelectrical activity, consistent with relief of functional gastric outlet obstruction.